Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported RAPP revenue for 2026-06-30 was $20.0M. Net income was -$76.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
Use this RAPP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RAPP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RAPP SEC filings page. Lician reads the product cache first so this HTML stays unique to Rapport Therapeutics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full RAPP income, balance, and cash tables.